Want to see HK:2477 full AI Analyst Report?
WellCell Holdings Co., Limited (2477) Ratios
0 Followers
WellCell Holdings Co., Limited Ratios
HK:2477's free cash flow for Q2 2026 was ¥-22.74M. For the 2026 fiscal year, HK:2477's free cash flow was decreased by ¥-2.33M and operating cash flow was ¥-20.41M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.03 | 2.42 | 1.98 | 1.89 | 1.91 |
| Quick Ratio | 2.01 | 2.42 | 1.98 | 1.89 | 1.91 |
| Cash Ratio | 0.48 | 0.85 | 0.25 | 0.50 | 0.29 |
| Solvency Ratio | 0.19 | 0.19 | 0.23 | 0.33 | 0.35 |
| Operating Cash Flow Ratio | -0.17 | -0.13 | 0.06 | 0.20 | 0.33 |
| Short-Term Operating Cash Flow Coverage | -0.67 | -0.38 | 0.25 | 0.77 | 5.66 |
| Net Current Asset Value | ¥ 117.85M | ¥ 174.67M | ¥ 88.59M | ¥ 75.81M | ¥ 64.87M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.14 | 0.15 | 0.18 | 0.06 |
| Debt-to-Equity Ratio | 0.15 | 0.22 | 0.33 | 0.37 | 0.12 |
| Debt-to-Capital Ratio | 0.13 | 0.18 | 0.25 | 0.27 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.04 | 0.09 | 0.05 |
| Financial Leverage Ratio | 1.54 | 1.62 | 2.16 | 2.02 | 2.11 |
| Debt Service Coverage Ratio | -0.16 | 0.57 | 0.94 | 1.23 | 5.87 |
| Interest Coverage Ratio | -11.13 | 23.78 | 22.12 | 33.56 | 80.63 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 |
| Net Debt to EBITDA | 5.60 | -2.36 | 0.16 | -0.36 | -0.40 |
| Profitability Margins | |||||
| Gross Profit Margin | 4.77% | 20.38% | 24.07% | 29.45% | 43.07% |
| EBIT Margin | -5.51% | 8.19% | 9.44% | 13.32% | 15.01% |
| EBITDA Margin | -1.96% | 9.30% | 10.28% | 14.67% | 16.13% |
| Operating Profit Margin | -5.51% | 7.50% | 9.36% | 13.28% | 14.99% |
| Pretax Profit Margin | 7.25% | 7.88% | 9.02% | 12.92% | 14.83% |
| Net Profit Margin | 7.02% | 7.24% | 7.97% | 10.71% | 12.55% |
| Continuous Operations Profit Margin | 6.97% | 7.24% | 7.97% | 10.71% | 12.55% |
| Net Income Per EBT | 96.74% | 91.90% | 88.36% | 82.89% | 84.66% |
| EBT Per EBIT | -131.66% | 104.98% | 96.34% | 97.33% | 98.91% |
| Return on Assets (ROA) | 4.51% | 6.19% | 11.11% | 14.87% | 17.03% |
| Return on Equity (ROE) | 6.95% | 10.05% | 23.95% | 30.05% | 35.91% |
| Return on Capital Employed (ROCE) | -5.44% | 10.37% | 26.85% | 37.77% | 40.88% |
| Return on Invested Capital (ROIC) | -4.57% | 7.85% | 17.67% | 24.51% | 32.51% |
| Return on Tangible Assets | 4.81% | 6.39% | 11.16% | 15.01% | 17.36% |
| Earnings Yield | 0.03% | 0.08% | 0.43% | 0.52% | 0.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.36 | 1.63 | 1.93 | 2.19 | 1.94 |
| Payables Turnover | 26.54 | 36.78 | 27.88 | 30.64 | 6.73 |
| Inventory Turnover | 85.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 14.86 | 19.24 | 171.55 | 89.42 | 63.80 |
| Asset Turnover | 0.64 | 0.86 | 1.39 | 1.39 | 1.36 |
| Working Capital Turnover Ratio | 1.45 | 2.07 | 3.06 | 3.17 | 3.28 |
| Cash Conversion Cycle | 259.79 | 213.75 | 176.23 | 154.53 | 133.70 |
| Days of Sales Outstanding | 269.27 | 223.67 | 189.32 | 166.44 | 187.93 |
| Days of Inventory Outstanding | 4.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 13.75 | 9.92 | 13.09 | 11.91 | 54.23 |
| Operating Cycle | 273.54 | 223.67 | 189.32 | 166.44 | 187.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | 0.00 | 0.01 | 0.01 |
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.00 | 0.01 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | -1.30 | -0.70 | 0.38 | 1.07 | 0.96 |
| Capital Expenditure Coverage Ratio | -1.30 | -0.70 | 81.50 | 13.13 | 12.37 |
| Operating Cash Flow Coverage Ratio | -0.63 | -0.36 | 0.21 | 0.56 | 3.02 |
| Operating Cash Flow to Sales Ratio | -0.09 | -0.06 | 0.02 | 0.07 | 0.12 |
| Free Cash Flow Yield | -0.07% | -0.16% | 0.12% | 0.34% | 0.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 3343.30 | 1183.18 | 234.55 | 192.19 | 168.47 |
| Price-to-Sales (P/S) Ratio | 226.16 | 85.65 | 18.69 | 20.58 | 21.15 |
| Price-to-Book (P/B) Ratio | 224.03 | 118.93 | 56.19 | 57.74 | 60.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1375.29 | -617.39 | 803.12 | 297.53 | 186.99 |
| Price-to-Operating Cash Flow Ratio | -2432.97 | -1494.47 | 793.27 | 274.86 | 171.87 |
| Price-to-Earnings Growth (PEG) Ratio | -108.66 | 0.00 | -14.61 | -40.84 | -3.45 |
| Enterprise Value Multiple | -11555.24 | 918.40 | 181.98 | 139.94 | 130.69 |
| Enterprise Value | 48.12B | 23.77B | 4.79B | 4.65B | 4.29B |
| EV to EBITDA | -11555.24 | 918.40 | 181.98 | 139.94 | 130.69 |
| EV to Sales | 226.05 | 85.43 | 18.71 | 20.53 | 21.08 |
| EV to Free Cash Flow | -1374.63 | -615.81 | 803.85 | 296.75 | 186.41 |
| EV to Operating Cash Flow | -2431.79 | -1490.64 | 793.99 | 274.15 | 171.34 |
| Tangible Book Value Per Share | 0.01 | 0.01 | 0.04 | 0.04 | 0.03 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.04 | 0.04 | 0.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | 0.08 | 0.12 | 0.17 | 0.15 |
| Revenue Per Share | 0.01 | 0.02 | 0.13 | 0.11 | 0.10 |
| Net Income Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Tax Burden | 0.97 | 0.92 | 0.88 | 0.83 | 0.85 |
| Interest Burden | -1.32 | 0.96 | 0.96 | 0.97 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.10 | 0.00 | 0.01 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.25 | -0.73 | 0.26 | 0.58 | 0.83 |
Currency in CNY
